PPAR agonists convey beneficial effects as therapeutic agents for diabetes and atherosclerosis by lowering blood glucose, improving insulin resistance, inflammation, and lipid metabolism; however, adverse side effects limit their clinical use. Here, PPARA is linked to Insulin resistance.